Company
About Lexcore AI Governance Contact
Research
Cortina Zero Neuromorphic Intelligence AI Sentience Lab BCI Research Synthetic Biology + AI Quantum-AI Convergence Neuro-Symbolic AI AHI Framework Organoid Lab EgoReversal Whitepaper
Products
All Products Naira AI Cortina Shield Deepfake Detection Cortina Naukri Agent NEO Lexcore AI
Invest
Investor Relations Capital Allocation Investment Deck
More
Blog Enterprise
Lexcore Research · Bio-AI Convergence

Engineering Life
With Intelligence.

AI has cracked protein folding. Now it is designing proteins that never existed in nature — custom enzymes with 90x improved activity, antibodies engineered for specific targets, and biological systems designed from scratch. The convergence of AI and synthetic biology is the most consequential scientific frontier of this century.

Protein DesignEnzyme EngineeringOrganoid AIBio-ComputingFinalSpark 2035
90xActivity boost
AI-designed enzymes (Nature 2025)
76.4%Accuracy
AlphaFold 3 ligand docking
78%Speech recognition
Brainoware organoid AI
2035Roadmap
Cortina biological substrate
01 / 02

The Convergence of AI and Biology

AlphaFold predicted protein structure. The next generation designs novel proteins. AI-guided enzyme engineering produces molecules evolution never found. Organoid intelligence uses lab-grown neurons as computing substrate. This is not biology with AI as a tool — it is a new hybrid field.

De Novo Protein Design
Beyond What Evolution Found
AlphaFold 3 predicts protein-DNA/RNA complexes at 76.4% accuracy. But companies like Cradle, Absci, and MIT's BoltzGen (Oct 2025) now design proteins that bind to arbitrary targets — no evolutionary precedent required. This is the AI equivalent of writing new DNA code, not just reading it.
2025–2026 Breakthrough
Enzyme Engineering
90x Activity Improvement
Nature Communications 2025 documented AI + biofoundry automation achieving 90-fold substrate preference improvement and 16-fold activity enhancement in a single enzyme. The same approach can redesign metabolic pathways, create novel catalysts, and produce drugs that cost-effectively target rare diseases.
Organoid Intelligence
Neurons as Computers
Brainoware (Indiana University) connected lab-grown brain organoids to AI systems and achieved 78% speech recognition accuracy using 90% less training data than silicon systems. Johns Hopkins' OI programme is formalising 'organoid computing' as a new field. Lexcore's Organoid Lab page addresses the biology — this page addresses the AI integration layer.
Lexcore Organoid Lab
RNA Therapeutics
AI Designing Medicine
AI-designed RNA therapies reached proof-of-concept for autism-linked genetic mutations in 2026 — not managing symptoms but addressing the underlying molecular biology. The design space for RNA therapeutics is vast and underexplored; AI is the only tool that can systematically navigate it.
02 / 02

Lexcore's Bio-AI Research Position

We sit at a specific intersection: the AI systems that interpret, design, and coordinate biological intelligence. Not wet lab biology — the computational layer that makes synthetic biology programmable at scale.

FinalSpark Partnership
The 2035 Biological Substrate
Lexcore's bio_bridge.py outlines the pathway to FinalSpark's organoid computing platform — real biological neurons used as the substrate for Cortina intelligence. FinalSpark's neuroplatform (2024) demonstrated 9x energy efficiency improvement using live neurons. Our 2035 target: Cortina running on a biological substrate.
2035 Mission
AI Drug Discovery
India's Pharmaceutical Advantage
India is the world's pharmacy — but AI drug discovery is happening in San Francisco, not Mumbai. Lexcore's synthetic bio research positions us to build the computational infrastructure for AI-guided drug design in India, connecting our AI capabilities to the country's existing pharmaceutical manufacturing base.

"Evolution had 3.8 billion years and a planet full of experiments. We have AI, and we are running faster."

— Lexcore Synthetic Biology Research, 2026
Lexcore Roadmap

Our Research Timeline

2024

bio_bridge.py

Lexcore maps FinalSpark organoid pathway — 2035 biological substrate plan documented

2026

Organoid Lab

Public research page on bio-AI convergence launched

2027

OI Collaboration

Partnership with Indian biotech for organoid AI feasibility study

2029

AI Enzyme Research

First Lexcore publication on AI-guided enzyme optimisation for Indian agricultural applications

2035

Cortina Bio-Substrate

Cortina intelligence running on FinalSpark-class organoid computing platform

System Specs

Current Status

Primary FocusAI computation layer for biology
Key ToolProtein language models
Organoid PartnerFinalSpark (2035 target)
India OpportunityAI drug discovery infrastructure
Current PhaseResearch & partnership building
StatusActive research track

Join the Bio-AI Convergence Research

We are seeking computational biologists, bioinformaticians, and pharma industry partners. The biology of intelligence is the final frontier.

Read Whitepapers Collaborate